Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2016

01-12-2016 | Erratum

Erratum to: Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry

Authors: Francesco Violi, Gino Roberto Corazza, Stephen Hugh Caldwell, Francesco Perticone, Angelo Gatta, Mario Angelico, Alessio Farcomeni, Michela Masotti, Laura Napoleone, Annarita Vestri, Valeria Raparelli, Stefania Basili, PRO-LIVER Collaborators

Published in: Internal and Emergency Medicine | Issue 8/2016

Login to get access

Excerpt

In the original publication, the second author name was incorrectly published as Roberto Gino Corazza. The correct name should read as “Gino Roberto Corazza”. …
Metadata
Title
Erratum to: Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry
Authors
Francesco Violi
Gino Roberto Corazza
Stephen Hugh Caldwell
Francesco Perticone
Angelo Gatta
Mario Angelico
Alessio Farcomeni
Michela Masotti
Laura Napoleone
Annarita Vestri
Valeria Raparelli
Stefania Basili
PRO-LIVER Collaborators
Publication date
01-12-2016
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 8/2016
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-016-1540-5

Other articles of this Issue 8/2016

Internal and Emergency Medicine 8/2016 Go to the issue

Obituary

Obituary

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine